Log in to save to my catalogue

Ataluren use in patients with nonsense mutation Duchenne muscular dystrophy: patient demographics an...

Ataluren use in patients with nonsense mutation Duchenne muscular dystrophy: patient demographics an...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_287625

Ataluren use in patients with nonsense mutation Duchenne muscular dystrophy: patient demographics and characteristics from the STRIDE Registry

About this item

Full title

Ataluren use in patients with nonsense mutation Duchenne muscular dystrophy: patient demographics and characteristics from the STRIDE Registry

Publisher

England: Future Medicine Ltd

Journal title

Journal of comparative effectiveness research, 2019-10, Vol.8 (14), p.1187-1200

Language

English

Formats

Publication information

Publisher

England: Future Medicine Ltd

More information

Scope and Contents

Contents

Strategic Targeting of Registries and International Database of Excellence (STRIDE) is an ongoing, multicenter registry providing real-world evidence regarding ataluren use in patients with nonsense mutation Duchenne muscular dystrophy (DMD) in clinical practice (NCT02369731). Here, we describe the initial demographic characteristics of the registr...

Alternative Titles

Full title

Ataluren use in patients with nonsense mutation Duchenne muscular dystrophy: patient demographics and characteristics from the STRIDE Registry

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_gup_ub_gu_se_287625

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_287625

Other Identifiers

ISSN

2042-6305

E-ISSN

2042-6313

DOI

10.2217/cer-2019-0086

How to access this item